TCM
OPTR

Touradji Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Touradji Capital Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$315K – 95
2013
Q3 		$315K Buy
+25,000
New +$331K 0.97% 34

Touradji Capital Management's OPTR Position: Q4 2013 in Review

Touradji Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 25,000 shares — an estimated $315K sold.

Touradji Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $315K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Touradji Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Touradji Capital Management sold 25,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $315K.
  • Touradji Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Touradji Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $315K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Touradji Capital Management's 13F filing for Q4 2013, filed 11 Feb 2014.